UK: GlaxoSmithKline and Pfizer to merge consumer health businesses
Leading healthcare and pharmaceuticals firm GlaxoSmithKline (GSK) and Pfizer have announced plans to merge their respective consumer health businesses in a move that will see GSK separate to create two new global companies. GSK said it would have a majority controlling equity interest of 68% in the joint venture, which has combined sales of approximately £9.8 billion ($12.7 […]
India: Unilever seals deal for GSK’s health consumer products division
FMCG giant Unilever has announced it has secured a deal to acquire GSK’s health consumer products division in India, Bangladesh and other predominantly Asian markets, for a total consideration of €3.3 billion ($3.8 billion). The transaction is said to consist of an all-equity merger of Hindustan Unilever Ltd with GSK Consumer Healthcare India, the acquisition of an 82% stake in […]
UK: GlaxoSmithKline to buy out stake in Novartis joint venture
GlaxoSmithKline (GSK), the UK based healthcare multinational, is to buy out its stake in its consumer healthcare venture with Novartis at a cost of $13 billion. The joint venture, which includes the toothpaste brand Sensodyne and painkiller brand Panadol, as well as Nicotinell stop smoking aids, was formed in 2015 as part of Novartis’ portfolio […]